Status:
COMPLETED
Open Label Trial to Assess Iressa in Prostate Cancer Patients
Lead Sponsor:
AstraZeneca
Conditions:
Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
A study to assess the activity of Iressa in patients who's prostate cancer has recurred, and who have rising PSA levels
Eligibility Criteria
Inclusion
- Prostate cancer diagnosis
- no evidence of metastasis
- Age 18 or older
Exclusion
- Prior chemotherapy for recurrent prostate cancer
- Radiotherapy completed within 28 days of starting the study
- Incomplete healing from prior cancer or other major surgery
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2003
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00635856
Start Date
May 1 2001
End Date
February 1 2003
Last Update
April 23 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.